Restriction of Dietary AGEs to Prevent Diabetes in Overweight Individuals

Status Completed

Clinical Trial Summary

Current efforts to arrest the epidemic of type 2 diabetes mellitus (T2DM) have had limited success. Thus there is an urgent need for effective approaches to prevent the development of T2DM. It is widely accepted that the current epidemic is driven by an increase in global food abundance and reduced food quality, making changes in diet a key determinant of the T2DM epidemic. Dietary factors can affect cardio-metabolic health; among these factors, advanced glycation end-products (AGEs) in food are potential risk factors for insulin resistance and T2DM. AGEs are a heterogeneous group of unavoidable stable bioactive compounds. Endogenous formation of AGEs is a continuous naturally occurring process, and is the result of normal metabolism. However, increased formation of AGEs occurs during ageing and under hyperglycaemic conditions. AGEs are implicated in the development of diabetes and vascular complications. Over the past several decades, methods of food processing have changed and meals now contain excess fat and sugar and are most susceptible for the formation of AGEs. In addition, AGEs in food are highly desirable due to their profound effect on shelf life, sterility, flavour, colour, and thus food consumption. Hence, a substantial portion of AGEs are derived from exogenous sources, particularly food. These exogenous AGEs are potential risk factors for insulin resistance and the development of T2DM. The investigators recently found that dietary AGEs represent a significant source of circulating AGEs, and have similar pathogenic properties compared to their endogenous counterparts including the development of insulin resistance and T2DM. Taken together, dietary AGEs are proposed to play a pivotal role in the development and progression of T2DM and its complications. Reduction of dietary intake of AGEs may therefore be an alternative strategy to reduce the risk of vascular disease and insulin resistance. The investigators therefore hypothesize that dietary restriction of AGEs in overweight individuals improves insulin sensitivity, β-cell function, and vascular function.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03866343
Study type	Interventional
Source	Maastricht University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	September 7, 2018
Completion date	March 3, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03995979` - Inflammation and Protein Restriction	N/A
Recruiting	`NCT06144905` - Norwegian Microbiota Study in Anorexia Nervosa
Completed	`NCT00983567` - An Interactive Web-Based Program to Improve Food and Activity Choices of Teens	N/A
Recruiting	`NCT06318377` - Peanuts and Neurocognitive / Cardiovascular Health in Black Individuals	N/A
Enrolling by invitation	`NCT05057039` - The Study of Gut Microbiota in Hypertensive Patients
Completed	`NCT04880525` - The Effect of a Weight-Loss Diet in Women Doing Reformer Pilates: A 12-Week Evaluation	N/A
Recruiting	`NCT04733300` - Online Mindfulness-Based College for Young Adults	N/A
Completed	`NCT05472454` - The Ready-to-Eat Meals for Cardiovascular Health Study	N/A
Recruiting	`NCT05394363` - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Active, not recruiting	`NCT05607745` - Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study	N/A
Completed	`NCT01475526` - The Value of Our Health	N/A
Completed	`NCT01249508` - Nutrition Labeling Program to Promote Healthy Dietary Patterns	N/A
Completed	`NCT04576260` - Effect of CBT Intervention to Improve Sleep on Wellbeing, Dietary Intake and Food Preference	N/A
Completed	`NCT03949543` - The Timing of Main Meal Consumption Effect on Gut Microbiota and Host	N/A
Completed	`NCT03350568` - Dietary Antioxidants and Chronic Diseases-The Swedish National March Cohort	N/A
Completed	`NCT04975529` - Game on Philly: Engaging Underserved Middle School Youth in Out-of- School Time Sports and Nutrition Education	N/A
Completed	`NCT00339677` - Recontacting Participants in the Observing Protein and Energy Nutrition (OPEN) Study: Re-OPEN
Recruiting	`NCT06152614` - MIND Foods and Aerobic Training in Black Adults With HTN	N/A
Completed	`NCT00870207` - Tu Salud Si Cuenta Worksite: Pilot Intervention Study	N/A
Completed	`NCT02653378` - The Effects of Acute Caloric Deprivation on Odour Identification and Food Reward	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.